Real-World Evidence in a Single Trial World – A Practical Guide
The new FDA single trial + confirmatory evidence standard can be confusing when applied to real-world evidence. We provide practical…
Resources and Insights
Deepening Our European Presence
Slipstream has long partnered with life sciences organizations across Europe. Today, we are formalizing that commitment in a meaningful way,…
Slipstream Expands Work Management and PMO Practice with Acquisition of Echolocity
Slipstream Life Sciences, a leading technology consulting partner, today announced the acquisition of Echolocity, a specialized work management and project management consultancy with more…
Slipstream Life Sciences Announces NIL Partnership with Amateur Golfer Miles Russell
Slipstream IT, a leading strategic technology partner to the life sciences industry, today announced a Name, Image, and Likeness (NIL)…
Two FDA Policy Changes That Are Reshaping Drug Development
In February 2026, the FDA made two announcements that will fundamentally change how drugs are developed, approved, and brought to…
Slipstream Co-Authors First Comprehensive Cost Study on Hereditary Hemorrhagic Telangiectasia in the American Journal of Hematology
Blue Bell, PA – July 10, 2025 – Slipstream, a trusted technology partner serving the Pharmaceutical and Biopharmaceutical industry, is proud…
In-Housing Omnichannel Orchestration
Overview Life sciences companies are rethinking how they allocate capital and resources for omnichannel orchestration. Early investments prioritized speed: fully…
AI in Pharma: From Experimentation to Execution
Executive Summary The life sciences industry is at a critical inflection point. Artificial intelligence (AI) has rapidly evolved from experimentation…
Slipstream Announces New Investment from GreyLion Partners and Denali Growth Partners
BLUE BELL, Pa. – August 5, 2025–Slipstream IT (“Slipstream”), a trusted technology partner serving the pharmaceutical and biopharmaceutical industry, today announced…
Accelerate What’s Next.
Connect with our team to design enterprise platforms, modern data foundations, and scalable operations that accelerate impact.